Human immunodeficiency virus infection, AIDS, and smoking cessation: The time is now

Raymond Niaura, William G. Shadel, Kathleen Morrow, Karen Tashima, Timothy Flanigan, David B. Abrams

Research output: Contribution to journalArticlepeer-review


Treatments for persons who are infected with human immunodeficiency virus (HIV) or who have developed AIDS have advanced to the point where death is no longer the inevitable outcome of diagnosis. Combination antiretroviral therapy has made HIV infection less of a terminal condition and more of a medically manageable chronic disease. Thus, efforts to improve the health status and quality of life of HIV-infected persons have become one of the highest treatment priorities for the next decade. Cigarette smoking is highly prevalent among HIV-infected persons, and quitting smoking would greatly improve the health status of these individuals. However, to date, no studies have evaluated the efficacy of a smoking-cessation intervention specifically tailored to this population. This article reviews the evidence and rationale for advancing smoking-cessation treatments specifically tailored to the needs of HIV-infected persons and provides recommendations for future treatment studies.

Original languageEnglish (US)
Pages (from-to)808-812
Number of pages5
JournalClinical Infectious Diseases
Issue number3
StatePublished - 2000

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'Human immunodeficiency virus infection, AIDS, and smoking cessation: The time is now'. Together they form a unique fingerprint.

Cite this